Drug Price Trends for ABILIFY

Average Pharmacy Cost for ABILIFY

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
ABILIFY 15 MG TABLET	59148-0009-13	18.62669	EACH	2025-03-19
ABILIFY 20 MG TABLET	59148-0010-13	26.42371	EACH	2025-03-19
ABILIFY 30 MG TABLET	59148-0011-13	26.47813	EACH	2025-03-19
ABILIFY 2 MG TABLET	59148-0006-13	18.70041	EACH	2025-03-19
ABILIFY 10 MG TABLET	59148-0008-13	18.71325	EACH	2025-03-19

Market Analysis and Price Projections for Abilify (Aripiprazole)

Market Overview

Abilify, known generically as aripiprazole, is an atypical antipsychotic medication widely used for treating conditions such as schizophrenia, bipolar disorder, and depression. Here’s a comprehensive look at the market analysis and price projections for this drug.

Market Size and Growth

The global aripiprazole drug market was valued at US$ 121 million in 2023 and is expected to reach US$ 167.1 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period from 2024 to 2030[1].

Competitive Landscape

The market for aripiprazole is dominated by several key players, including Otsuka Pharmaceutical, Teva, APOTEX, Barr Laboratories, Sun Pharmaceutical, and others. These companies play a significant role in the production and distribution of both the brand-name and generic versions of the drug[1].

Brand Name vs. Generic Pricing

The cost of Abilify can vary significantly depending on whether you are purchasing the brand-name or generic version.

Brand Name Abilify

The brand-name version of Abilify is quite expensive, with the average retail price for a 30-day supply ranging from $800 to $1,000 per month. For example, a 30-day supply of 2 mg Abilify oral tablets can cost around $624, depending on the pharmacy[5].

Generic Abilify

The introduction of generic aripiprazole has made the medication more accessible. Generic Abilify prices typically range from $30 to $150 for a month’s supply, depending on the dosage and pharmacy. Here are some general estimates:

• 30-day supply of 10 mg: Approximately $50 – $100
• 30-day supply of 15 mg: Approximately $60 – $110
• 30-day supply of 30 mg: Approximately $70 – $120[3].

Factors Affecting Pricing

Several factors influence the cost of Abilify:

Pharmacy Pricing

Different pharmacies offer varying prices for the same medication. For instance, prices for a 30-day supply of Abilify can range from $268.46 at CVS Pharmacy to $791.93 at Kroger Pharmacy[2].

Insurance Coverage

Insurance plans can cover the cost of generic medications differently, affecting the out-of-pocket costs for patients. Most insured patients pay between $10 to $50 for a copay, depending on their plan[3].

Manufacturer Pricing

Various manufacturers produce generic Abilify, which can affect the price. The cost can also vary based on the dosage strength of the medication[3].

Location

Prices can differ by region and local market conditions. Discount programs offered by pharmacies can also significantly reduce out-of-pocket costs[3].

Impact of Patent Expiry

The patent expiry of Abilify Maintena, a long-acting injectable (LAI) version of aripiprazole, in October 2024 in both Europe and the US is expected to significantly impact the market. The introduction of generic versions will lead to a decline in sales for the brand-name drug. The compound annual growth rate (CAGR) for Abilify Maintena’s global sales is projected to be negative 21% from 2024 to 2029[4].

Future Market Trends

Increased Accessibility

The introduction of generic versions and the approval of new formulations, such as Abilify Asimtufii (a once-every-two-month LAI), will make the medication more accessible to a larger patient population. This shift is expected to benefit patients by offering competitive pricing and improved treatment options[4].

Strategic Positioning by Manufacturers

Otsuka and other manufacturers are positioning themselves strategically to maintain their market presence despite the impending patent expiries. The approval of new formulations and the expansion of product lines are key strategies to continue making a meaningful impact on patients’ lives[4].

Cost Estimates and Projections

Current Costs

• Brand Name: $800 to $1,000 per month for a 30-day supply.
• Generic: $30 to $150 per month for a 30-day supply, depending on dosage and pharmacy[3][5].

Future Projections

• The global aripiprazole market is expected to grow at a CAGR of 5.1% from 2024 to 2030, reaching US$ 167.1 million by 2030[1].
• The sales of Abilify Maintena are expected to decline significantly due to patent expiry, with a projected CAGR of -21% from 2024 to 2029[4].

"Despite the requirement for in-office injections monthly, its efficacy and convenience have driven strong revenue growth since its approval in 2013, making Abilify Maintena one of the leading LAI antipsychotics by sales in 2024 with forecast sales of $1.5bn."[4]

Key Takeaways

• The global aripiprazole market is expected to grow at a CAGR of 5.1% from 2024 to 2030.
• Generic versions of Abilify are significantly cheaper than the brand-name version.
• Patent expiry of Abilify Maintena will lead to a decline in sales but increase accessibility due to generic competition.
• Manufacturers are strategically positioning themselves with new formulations to maintain market presence.

FAQs

What is the current market size of the aripiprazole drug market?

The global aripiprazole drug market was valued at US$ 121 million in 2023[1].

How much does a 30-day supply of brand-name Abilify cost?

A 30-day supply of brand-name Abilify can cost between $800 to $1,000 per month[3][5].

What factors affect the cost of generic Abilify?

The cost of generic Abilify can vary based on pharmacy pricing, insurance coverage, manufacturer pricing, dosage strength, and location[3].

What is the impact of patent expiry on Abilify Maintena sales?

The patent expiry of Abilify Maintena is expected to lead to a decline in sales, with a projected CAGR of -21% from 2024 to 2029[4].

How will the introduction of generic versions affect the market?

The introduction of generic versions will increase accessibility and reduce costs for patients, but it will also lead to a decline in sales for the brand-name drug[4].

What new formulations are being introduced by manufacturers?

Otsuka has introduced Abilify Asimtufii, a once-every-two-month LAI, to maintain its market presence[4].

Sources

1. Global Aripiprazole Drug Market Research Report 2024 - Valuates Reports
2. Abilify Coupons & Prices - SingleCare
3. Understanding the Cost of Abilify: A Comprehensive Guide - Starski
4. Otsuka's Abilify Maintena: dual drug expiry signals sales decline - Pharmaceutical Technology
5. Abilify Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com